RE: There goes October 2021 -LFT sales by October 2022?1 Nov 2021 10:24
PL75...If max production rates are 1m (for pro use only) and we are selling every bit of each production run and customers are indicating they would take more then we are already in a position of selling into production scale up. How far along we are on production scale up and how much we are able to sell into that we don't know. But lets say we have scaled up and we are selling into that production, then it would leave only a percentage of those new production levels for the wider HUA market etc.
From an Avacta financed production point of view, how much would they scale up in advance of HUA? If they were told it could take to the end of the year to get HUA, would you be scaling up significantly now?
Selling into production scale up is good when you have all the right approvals, active Distributor(s)/customers.
Scaling up with no HUA approval in hand might not be so good.
It's all about timing, timing, timing...
Medusa19 are ready to go, so they must have their stocks/production access sorted. If they are ready to go now, does that mean they believe HUA is imminent. They are able to sell the Avacta LFT (for pro use) to the NHS under the NHS Microbiology Framework so they will have access to product for any order call offs through this programme. How much have they been able to shift to the NHS again we simply don't know.
BTW has anyone been able to communicate with FTI Consulting recently? I'm getting blanked.....